MetLife, Inc. $MET Shares Acquired by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA increased its holdings in MetLife, Inc. (NYSE:MET) by 13.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 984,685 shares of the financial services provider’s stock after acquiring an additional 114,959 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in MetLife were worth $77,731,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of MET. Vermillion & White Wealth Management Group LLC increased its holdings in shares of MetLife by 790.0% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 316 shares during the period. Sound Income Strategies LLC grew its position in MetLife by 58.9% in the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after buying an additional 142 shares during the last quarter. Foster Dykema Cabot & Partners LLC purchased a new position in MetLife in the 3rd quarter valued at $32,000. Albion Financial Group UT purchased a new position in MetLife in the 4th quarter valued at $32,000. Finally, JPL Wealth Management LLC purchased a new position in MetLife in the 3rd quarter valued at $33,000. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Price Performance

MetLife stock opened at $75.42 on Tuesday. MetLife, Inc. has a one year low of $67.33 and a one year high of $83.85. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The business has a fifty day moving average of $73.10 and a two-hundred day moving average of $76.91. The company has a market cap of $49.18 billion, a P/E ratio of 16.05, a price-to-earnings-growth ratio of 0.66 and a beta of 0.74.

MetLife (NYSE:MET) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, beating analysts’ consensus estimates of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The company had revenue of $52.44 billion during the quarter, compared to the consensus estimate of $31.43 billion. During the same quarter last year, the company earned $2.08 earnings per share. MetLife’s quarterly revenue was up 27.6% compared to the same quarter last year. As a group, analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: UBS raised its price target on MET to $102, signaling greater analyst optimism about earnings power and valuation upside. UBS raises price target
• Positive Sentiment: MetLife Foundation announced over $6.5M in global grants to address community needs — a positive ESG/brand item that can support reputation and stakeholder goodwill. MetLife Foundation grants
• Neutral Sentiment: Coverage-piece on MetLife’s deal with PineBridge and a push into private credit — this strategic shift could boost investment yields and recurring income but also raises illiquidity and credit-risk considerations for investors. PineBridge & private credit analysis
• Neutral Sentiment: MetLife Stadium will temporarily be renamed (e.g., “New York New Jersey Stadium”) for the FIFA World Cup due to FIFA sponsorship rules — a short-term reduction in visible MetLife branding during a high-profile event; PR impact is limited and temporary. Stadium name change explanation
• Neutral Sentiment: Local transit plans for the World Cup (partial Penn Station closures and commuter discounts) add event logistics uncertainty that could affect attendance patterns around stadium events but are unlikely to materially affect MetLife’s financials. Commuter discounts for Penn Station closure
• Negative Sentiment: Wells Fargo cut its MET price target to $90, introducing a bearish analyst view that could cap near-term upside and pressure sentiment among institutional holders. Wells Fargo cuts price target

Wall Street Analysts Forecast Growth

MET has been the topic of a number of analyst reports. UBS Group lifted their price objective on shares of MetLife from $98.00 to $102.00 and gave the company a “buy” rating in a research report on Thursday, April 9th. Barclays lowered their price objective on shares of MetLife from $92.00 to $89.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. TD Cowen lowered their price objective on shares of MetLife from $91.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, March 11th. Wall Street Zen upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Mizuho lowered their price objective on shares of MetLife from $100.00 to $93.00 and set an “outperform” rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.92.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.